Maintenance of niaid specific pathogen-free macaque breeding colonies
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
Alpha Genesis Inc. UEI H7E8FHEF7ND5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,604,563
Award facts
- Contract value 100% obligated
- $3,604,563.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Yemassee, SC, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$103,198 | |
| Funding Only Action | $300,000 | |
| Other Administrative Action | $0 | |
| Original award | $3,407,761 |
About this award
This federal contract award, valued at $3,604,563.44, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Alpha Genesis Inc., a for-profit subchapter S corporation based in Yemassee, South Carolina. The contract is for the maintenance of NIAID's specific pathogen-free macaque breeding colonies, which support critical biomedical research programs across multiple NIH institutes, including research into infectious diseases, COVID-19 vaccine development, immunology, and mental health.
This contract is a delivery order issued under a larger $48 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract held by Alpha Genesis for the provision of specific pathogen-free macaque breeding colonies to support NIAID's research programs. The contract does not utilize any set-aside designations, indicating that Alpha Genesis competed broadly for this award. In addition to this IDIQ, Alpha Genesis also holds a separate $33.4 million IDIQ contract with the NIH Office of Logistics and Acquisition Operations for the acquisition, testing, transportation, and housing of nonhuman primates across multiple federal research agencies.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to Alpha Genesis Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $3,604,563 on 75N93020F00002.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under HHSN272201700046I, an indefinite delivery contract.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award